|

Octreotide
|
|
Researchers scanned the surface of liver cysts with an electron microscope. The surface contained: hormone receptors, insulin growth hormone receptors and growth hormone receptors. Octreotide inhibits growth hormone; inhibits insulin growth hormone; and inhibits estrogen like hormones.
Octreotide is the first drug ever to be in clinical trials for PLD, Polycystic Liver Disease. These trials are going on around the world: Italy, Belgium, Netherlands, USA Rochester Minnesota to test for the efficacy and if it will reduce cystic liver size. The above articles include a case study and a short completed [6 month] lanreotide - octreotide clinical trial.The results are very promising.
|